4-Bromo-5-chloro-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g

2-Ethynylcyclopentanol, 95.0%, 1g

1-(2,2-difluoroethyl)-1H-pyrazole-3-carboxylic acid, 95.0%, 100mg

Vigreux column with fused-on vacuum shell, 300 mm, 29/32, 1 Piece

Methyl p-Anisate>99.0%(GC)100g

Spiro[indene-1,4'-piperidine], 95.0%, 1g

2-(1,4-Diazepan-1-yl)-1,3-benzothiazole, 95.0%, 1g

(SP-5-13)-Chloro[[2,2'-[1,2-ethanediylbis[(nitrilo-?N)methylidyne]]bis[4,6-bis(1,1-dimethylethyl)phenolato-?O]](2-)]manganese, 97%, 10g

4-Methyl-2-pyridin-3-yl-thiazole-5-carboxylic acid, 97.0%, 25g

Methyl 3-formyl-1H-indole-5-carboxylate, 97.0%, 250mg

3,5-Dibromo-4-butoxybenzaldehyde, 98%, 1g

3-Amino-5-(4-fluorophenyl)thiophene-2-carboxamide, 1g

3,5-Difluoro-4-methylphenylboronic acid pinacol ester, 98%, 500mg